Lalit Mohan Negi

Employment

Employment history is unavailable.

Education

• Jamia Hamdard PhD
  2010 - 2014
• Delhi Institute of Pharmaceutical Sciences and Research M. Pharm
  2007 - 2009
• Delhi Institute of Pharmaceutical Sciences and Research B. Pharm
  2004 - 2007
• Delhi Institute of Pharmaceutical Sciences and Research D. Pharm
  2002 - 2004

Projects & Funding

Projects & funding information is unavailable.

Publications (18)

• Hyaluronated imatinib liposomes with hybrid approach to target CD44 and P-gp overexpressing MDR cancer: an in-vitro, in-vivo and mechanistic investigation
  Journal of Drug Targeting 2019 DOI: 10.1080/1061186x.2018.1497039
  +Save
• Novel flavonoid-based biodegradable nanoparticles for effective oral delivery of etoposide by P-glycoprotein modulation: anin vitro, ex vivoandin vivoinvestigations
  Drug Delivery 2016 DOI: 10.3109/10717544.2014.923956
  +Save
• Design and development of novel bioadhesive niosomal formulation for the transcorneal delivery of anti-infective agent: In-vitro and ex-vivo investigations
  Asian Journal of Pharmaceutical Sciences 2015 DOI: 10.1016/j.ajps.2015.02.001
  +Save
• Hyaluronan coated liposomes as the intravenous platform for delivery of imatinib mesylate in MDR colon cancer
  International Journal of Biological Macromolecules 2015 DOI: 10.1016/j.ijbiomac.2014.11.026
  +Save
• Hyaluronic acid decorated lipid nanocarrier for MDR modulation and CD-44 targeting in colon adenocarcinoma
  International Journal of Biological Macromolecules 2015 DOI: 10.1016/j.ijbiomac.2014.09.005
  +Save
• Liquid chromatographic method for irinotecan estimation: Screening of p-gp modulators
  Indian Journal of Pharmaceutical Sciences 2015 DOI: 10.4103/0250-474x.151577
  +Save
• Addressing the potential toxicities of the non-specific P-glycoprotein modulation by amalgamation with targeted approach in MDR tumors
  Medical Hypotheses 2014 DOI: 10.1016/j.mehy.2013.12.006
  +Save
• Development of protocol for screening the formulation components and the assessment of common quality problems of nano-structured lipid carriers
  International Journal of Pharmaceutics 2014 DOI: 10.1016/j.ijpharm.2013.12.006
  +Save
• Surface engineered nanostructured lipid carriers for targeting MDR tumor: Part II. In vivo biodistribution, pharmacodynamic and hematological toxicity studies
  Colloids and Surfaces B: Biointerfaces 2014 DOI: 10.1016/j.colsurfb.2014.09.061
  +Save
• Surface engineered nanostructured lipid carriers for targeting MDR tumor: Part I. Synthesis, characterization and in vitro investigation
  Colloids and Surfaces B: Biointerfaces 2014 DOI: 10.1016/j.colsurfb.2014.09.062
  +Save